Lumira Capital joins Cardiac Dimensions' $39 mln Series B
Cardiac Dimensions, a U.S. developer of minimally invasive treatments for patients with heart failure, has secured US$39 million in a Series B financing. The round was backed by Australia's Hostplus, a new investor in the company, as well as venture debt from Oxford Finance and support from existing investors, among them Canadian life sciences venture capital firm Lumira Capital. Cardiac, which has its headquarters in Kirkland, Washington, will use the funds raised for clinical studies, including for its Carillon Mitral Contour System, and for commercial expansion in Europe and Australia.
26 April 2018•5 mins read
